Relaxin
The word Botox has become a part of our everyday lexicon. With over 3 million Botox procedures performed in the US alone last year, ever increasing applications of the “wonder drug” and increasing consumer demand and awareness of its inherent safety profile, there is no question that Botox has secured its place in every aesthetic Physician’s medication fridge.
The “new” injection is being marketed as Relaxin (Dysport) and is currently under review by the FDA for distribution and utilization within the US. reloxin ( http://prohormone.ru/?
Reloxin has less of a protein load than Botox. Clinically this means that Reloxin will result in the formation of fewer antibodies against it. Antibodies are what our bodies use to detect and destroy foreign proteins aka antigens (the injected medications)
However in the United Kingdom, this dilution has resulted in more cost effectiveness where 100 units of Botox goes for $525.00 and 500 units of Reloxin is $300.00.
Recent clinical studies have shown that a new version botulotoksina able to be regarded as conservative cosmetic treatment of the problem of wrinkles.
Toxin called Reloxin 1200 is well tolerated by all patients who participated in the experiment to study the drug for 13 months, with marked improvement in the skin.
Patients received five injections Reloxin in the upper part of the face at the beginning of each therapeutic cycle, and after seven days, were questioned, with subsequent clinical studies at least once a month.
The refusal of further participation in the study due to side effects (such as headaches, the omission of the century, or eyebrows) was recorded in one patient.
As they say the authors of the study in the latest issue of Archives of Facial Plastic Surgery, the effects of treatment are beginning to emerge in the 24 hours after the injection, with the observation of positive dynamics of the 93% -95% of patients who participated in the study.
Photo:
http://www.prlog.org/
